Skip to main content

Analysts Conflicted on These Real Estate Names: Douglas Emmett (DEI) and Macerich (MAC)

Tipranks - Tipranks - Fri Feb 20, 7:16AM CST

Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Douglas Emmett (DEI – Research Report) and Macerich (MAC – Research Report).

President's Day Sale - 70% Off

Douglas Emmett (DEI)

Bank of America Securities analyst Jana Galan reiterated a Sell rating on Douglas Emmett on February 17 and set a price target of $13.00. The company’s shares closed last Wednesday at $9.83.

According to TipRanks.com, Galan is a 1-star analyst with an average return of -3.7% and a 46.9% success rate. Galan covers the NA sector, focusing on stocks such as Essential Properties Realty, Hudson Pacific Properties, and Mid-America Apartment. ;'>

Douglas Emmett has an analyst consensus of Hold, with a price target consensus of $12.72.

See Insiders’ Hot Stocks on TipRanks >>

Macerich (MAC)

In a report released today, Michael Lewis from Truist Financial maintained a Buy rating on Macerich. The company’s shares closed last Wednesday at $19.15.

According to TipRanks.com, Lewis is a 5-star analyst with an average return of 9.5% and a 65.3% success rate. Lewis covers the NA sector, focusing on stocks such as SmartStop Self Storage REIT, Inc., Easterly Government Properties, and American Healthcare REIT, Inc. ;'>

Currently, the analyst consensus on Macerich is a Moderate Buy with an average price target of $20.33.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).